Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-16-113546)

Filing Details

Accession Number:: 0001144204-16-113546
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-07-19 15:50:14
Reporting Period:: 2016-07-18

Filing Date:: 2016-07-19
Accepted Time:: 2016-07-19 15:50:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
910267	Titan Pharmaceuticals Inc	TTNP	Biological Products, (No Disgnostic Substances) (2836)	943171940

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1180755	Sunil Bhonsle	400 Oyster Point Blvd., Suite 505 So. San Francisco CA 94080	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-07-18	10,000	$4.96	135,578	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	54,684	Indirect	By Family Trust

Footnotes

Represents the weighted average purchase price for the reported transactions. 5,000 of such shares were purchased at $4.95 and 5,000 were purchased at $4.96.
The reporting person serves as trustee of the family trust.